FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/27/2023
Back to search
Official data from USPTO
NEURO B-FORMULA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEURO B-FORMULA
ST13
US500000079285474Class
5
Filing
79285474
Registration
6874440
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
02/27/2023
Trademark type
Word
Nice classes
5
Filing date
11/29/2019
Registration date
10/18/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/18/2022
Last transaction
10/18/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AT
Examiner
KELLY, JOHN
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Biogena GmbH & Co KG
Biogena Naturprodukte GmbH & Co KG
Representatives
Jeff Goehring Nixon & Vanderhye
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparationsnutraceuticals for use as a dietary supplement; sanitary preparations for medical purposes; dietetic food and substances adapted for medical and veterinary usein particular dietetic foods for a balanced diet adapted for medical and veterinary use; starch for pharmaceutical purposes; diatetic starch for medical purposes; food for babiesin particular powdered milk for babies; dietary supplements for humans and animals for medical purposesin particular antioxidants for humans and animals for medical purposesnutritional supplements and dietetic food supplements for sports and performance enhancementadapted for medical use; meal replacement powders for sports and performance enhancement for medical use; mineral food supplementsconsisting primarily of vitaminsamino acidsminerals and trace elementsadapted for medical purposes; vitamin preparations; dietetic preparations adapted for medical purposesfor making medicated dietetic beverages; drinks for medical purposesin particular herbal teas for medicinal purposes; medical plasters; materials for surgical dressings; material for dental fillings and dental impressions; disinfectants; preparations for destroying noxious animals; fungicidesherbicides
Publications
History of USPTO decisions and trademark events.
40 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/02/2023
FIMP
FINAL DISPOSITION PROCESSED
02/02/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/18/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/18/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/18/2022
GPNX
NOTIFICATION PROCESSED BY IB
08/09/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/02/2022
PUBO
PUBLISHED FOR OPPOSITION
08/02/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/13/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/13/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/13/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/28/2022
ALIE
ASSIGNED TO LIE
06/28/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/20/2022
ZZBX
ALLOWANCE WITHDRAWN-INADVERTENTLY ISSUED ACTION
02/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/08/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/08/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/20/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/20/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/17/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/16/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/16/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/16/2021
GNRT
NON-FINAL ACTION E-MAILED
02/16/2021
CNRT
NON-FINAL ACTION WRITTEN
02/16/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/28/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/28/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
11/07/2020
RFNT
REFUSAL PROCESSED BY IB
07/18/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/26/2020
RFRR
REFUSAL PROCESSED BY MPU
06/25/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/24/2020
CNRT
NON-FINAL ACTION WRITTEN
05/23/2020
MAFR
APPLICATION FILING RECEIPT MAILED
05/19/2020
DOCK
ASSIGNED TO EXAMINER
05/15/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/15/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/14/2020
Continuous trademark protection
Get notified about every new filing that threatens NEURO B-FORMULA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.